Article
KRAS Oncogenic Signaling Extends beyond Cancer Cells to Orchestrate the Microenvironment.
Cancer research - 1 Jan 2018
Dias Carvalho Patrícia, Guimarães Carlos F, Cardoso Ana P, Mendonça Susana, Costa Ângela M, Oliveira Maria J, Velho Sérgia
Abstract excerpt
KRAS is one of the most frequently mutated oncogenes in cancer, being a potent initiator of tumorigenesis, a strong inductor of malignancy, and a predictive biomarker of response to therapy. Despite the large investment to understand the effects of KRAS activation in cancer cells, pharmacologic targeting of KRAS or its downstream effectors has not yet been successful at the clinical level. Recent studies are now...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
